Authors contributed equally to the manuscript.
Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs
Version of Record online: 18 JUL 2014
© 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Volume 13, Issue 5, pages 850–861, October 2014
How to Cite
Olivieri, F., Ahtiainen, M., Lazzarini, R., Pöllänen, E., Capri, M., Lorenzi, M., Fulgenzi, G., Albertini, M. C., Salvioli, S., Alen, M. J., Kujala, U. M., Borghetti, G., Babini, L., Kaprio, J., Sipilä, S., Franceschi, C., Kovanen, V. and Procopio, A. D. (2014), Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs. Aging Cell, 13: 850–861. doi: 10.1111/acel.12245
[Correction added on 7 August 2014, after first online publication: miR-233 was corrected to miR-223 in both the title and keywords of the article.]
- Issue online: 19 SEP 2014
- Version of Record online: 18 JUL 2014
- Manuscript Accepted: 7 JUN 2014
- Academy of Finland. Grant Numbers: 213506, 129680, 265240, 263278, 114310
- Finnish Ministry of Culture and Education to Vuokko Kovanen
- Università Politecnica delle Marche. Grant Number: RSA 2010-2011
Table S1 Common targets for hsa-miR-142-3p (250 elements), hsa-miR-182 (841 elements) and hsa-miR-223 (202 elements).
Table S2 The oligonucleotides used for the luciferase activity assays.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.